Crinetics (CRNX) analyst forecast and price target
Analyst forecast
Consensus of 13 analyst ratings
Based on 7 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| UBS | Downgraded | Buy → Neutral | $85.00 from $55.00 | Jul 28, 2026 |
| Evercore ISI Group | Downgraded | Outperform → In-Line | $85.00 from $88.00 | Jul 8, 2026 |
| TD Cowen | Downgraded | Buy → Hold | — | Jul 8, 2026 |
| Baird | Maintained | Outperform | $85.00 from $62.00 | Jul 7, 2026 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | $85.00 from $81.00 | Jul 7, 2026 |
| Oppenheimer | Downgraded | Outperform → Perform | — | Jul 7, 2026 |
| Jones Trading | Downgraded | Buy → Hold | $85.00 | Jul 7, 2026 |
| Jefferies | Downgraded | Buy → Hold | $85.00 from $55.00 | Jul 7, 2026 |
| Cantor Fitzgerald | Downgraded | Overweight → Neutral | — | Jul 7, 2026 |
| UBS | Initiated Coverage | Buy | $55.00 | Jul 2, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $81.00 | Jun 15, 2026 |
| Citizens | Maintained | Market Outperform | $95.00 | Jun 11, 2026 |
| Evercore ISI Group | Maintained | Outperform | $88.00 from $89.00 | May 15, 2026 |
| Oppenheimer | Maintained | Outperform | $84.00 from $87.00 | May 11, 2026 |
| Citizens | Maintained | Market Outperform | $95.00 from $97.00 | May 8, 2026 |
| Citizens | Maintained | Market Outperform | $97.00 from $96.00 | Apr 28, 2026 |
| Citizens | Maintained | Market Outperform | $96.00 from $105.00 | Mar 2, 2026 |
| Goldman Sachs | Upgraded | Neutral → Buy | $67.00 | Jan 12, 2026 |
| Citizens | Maintained | Market Outperform | $105.00 from $108.00 | Jan 8, 2026 |
| Morgan Stanley | Maintained | Overweight | $80.00 from $77.00 | Jan 6, 2026 |
Frequently asked questions
What is the price target for CRNX stock?
The average 12-month analyst price target for Crinetics (CRNX) is $86.43, with a high estimate of $95.00 and a low of $85.00, across 7 analysts.
Is CRNX a buy, sell, or hold?
Analysts covering Crinetics currently average a Hold rating: 1 buy, 12 hold and 0 sell, from 13 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for CRNX?
The average price target of $86.43 implies 1.69% upside from the last price of $84.99.
What is the latest analyst rating on CRNX?
On Jul 28, 2026, UBS downgraded Crinetics to Neutral with a price target of $85.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.